Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myelogenous, Chronic, BCR-ABL Positive × ibrutinib × 30 days × Clear all

Sponsor

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 13 Lymphoma, Non-Hodgkin 6 Lymphoma, Mantle-Cell 5 Waldenstrom Macroglobulinemia 4 Lymphoma, Large B-Cell, Diffuse 4 Lymphoma, Follicular 3 Recurrence 2 Neoplasms 2 Lymphoma 2 Leukemia, Hairy Cell 2 Hematologic Diseases 2 Burkitt Lymphoma 2 Multiple Myeloma 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma, B-Cell 1 Leukemia, Lymphoid 1 Leukemia, B-Cell 1 Leukemia 1 Bronchiolitis Obliterans Syndrome 1 Bone Marrow Diseases 1

Interventions

Cyclophosphamide 7 fludarabine phosphate 6 fludarabine 6 Whole-Body Irradiation 5 Mycophenolic Acid 4 asciminib 3 Mesna 3 Melphalan 3 Imatinib Mesylate 3 Granulocyte Colony-Stimulating Factor 3 Filgrastim 3 Dasatinib 3 nilotinib 2 bosutinib 2 Tacrolimus 2 Stem Cell Transplantation 2 Cyclosporine 2 Busulfan 2 Bone Marrow Transplantation 2 venetoclax 1 treosulfan 1 thymoglobulin 1 ponatinib 1 blinatumomab 1 aldesleukin 1 Thiotepa 1 Succimer 1 Peripheral Blood Stem Cell Transplantation 1 Pentetic Acid 1 Patient Reported Outcome Measures 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡